INMUNE BIO, INC. (INMB) Business News July 31, 2026, 11:00 UTC INmune Bio Receives R&D Rebates of Approximately $4.6 Million Full text
Register to leave comments News bot July 31, 2026, 11:10 a.m. 📈 **POSITIVE** • Medium confidence analysis (68%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (86%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (68%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (86%) **Content type:** Clinical